24 Mar
24Mar


Recent outbreaks are causing us to take another look at Measles. It has posed a serious threat in many parts of the world, but we seem to be looking at a resurgence in the US.  As of March 20, 2025 the CDC reports a total of 378 confirmed cases in18 jurisdictions.  

Of the 378 cases, 42% were in the 5-19 age group and 33% were under 5.  The vaccination status was 95% unvaccinated or unknown, and only 2% had the two doses of MMR.  Just as important, 17%, or 64 of the 378, were hospitalized.  Deaths-2.   

Facts:  Measles are an airborne, extremely infectious and potentially severe rash illness.  It is not a seasonal virus, but it seems to peak and spread over times of travel, like spring break or where unvaccinated people gather, like summer camp.

People that have received 2 MMRs rarely get the disease.  If only one MMR, the vaccine is 93% effective. Breakthrough infections can occur.  Staff working in hospitals can have the blood titre level checked or received a vaccine if they have no immunization records.   You too, can request a titre to confirm whether you have had measles or not from your private HCP.

Symptoms:  Measles symptoms appear 7-14 days after contact with the virus.  This article is aimed at adult symptoms.  (Check the CDC.com for children's symptoms).  High fever possibly spiking to 104, cough, runny nose, and red, watery eyes.  Two to three days later Koplik spots may appear inside the mouth. Koplikspots.com.  Within 3-5 days after symptoms begin, a measles rash appears.  They are red and usually appear first at the hairline, then descend across the body.  Ear or sinus infections may occur, and diarrhea is a possibility. One in 5 unvaccinated people will require hospitalization, one out of 20 develop pneumonia and the risk of encephalitis or death are a risk.

Measles was eliminated in the US as of 2000.  That is no longer the case.

Be aware of the symptoms, risks, etc.  

As always, know your body and stay educated about current science and risks.

**CDC, March 2025


                      



Comments
* The email will not be published on the website.